What are United Therapeutics's profit margins?

United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.

Where do United Therapeutics's ratios come from?

Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

United Therapeutics UTHR Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	86.6%-2.4pp	87.9%-1.3pp	88.6%-0.3pp	89%+0.1pp	89%+0.1pp
Operating margin	45.3%-1.6pp	46.9%-1.0pp	47.7%+1.3pp	47%-1.2pp	46.9%-3.4pp
Net margin	40.6%+0.2pp	41.9%+0.4pp	40.7%+0.3pp	40.4%-0.5pp	40.4%-1.6pp
EBITDA margin	48.1%-1.4pp	49.6%-0.8pp	50.4%+1.5pp	49.6%-1.0pp	49.5%-3.0pp
Free cash flow margin	32.1%-5.6pp	32.7%-4.9pp	35.9%+3.3pp	34.8%+1.2pp	37.7%+7.6pp
Returns
Return on equity	20.3%+0.3pp	19.7%+0.5pp	20%+1.2pp	19.3%0.0pp	19.9%-0.1pp
Return on assets	17.8%+0.8pp	17.5%+1.1pp	17.6%+1.9pp	17%+1.0pp	17%+0.6pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Inventory turnover	2.5×+0.2×	2.3×0.0×	2.2×-0.2×	2.2×-0.2×	2.3×-0.2×
Liquidity
Current ratio	4.8×-0.7×	6.6×+1.4×	6.4×+1.8×	7.3×+2.9×	5.5×+1.7×
Quick ratio	4.5×-0.7×	6.3×+1.2×	6.1×+1.7×	6.9×+2.8×	5.2×+1.6×
Cash ratio	2.1×-0.5×	2.8×+0.5×	2.5×+0.7×	3×+1.4×	2.6×+1.2×
Leverage
Interest coverage	87.5×+48.2×	76.5×+44.4×	61.5×+35.9×	46.1×+23.4×	39.3×+17.9×
Per Share
Book value per share	$125.02-10.7%	$148.15+11.5%	$139.33+10.5%	$148.52+23.8%	$140.07+30.4%
Valuation
Market capitalization	$25.99B+87.7%	$20.98B+33.2%	$18.96B+19.2%	$13.08B-12.6%	$13.85B+28.2%
Price / earnings	20.2×+8.8×	15.7×+2.5×	14.9×+0.6×	10.5×-3.5×	11.4×+1.2×
Price / sales	8.2×+3.6×	6.6×+1.1×	6.1×+0.3×	4.2×-1.5×	4.6×+0.3×
Price / book	4.4×+2.4×	3×+0.5×	2.9×+0.3×	1.8×-0.8×	2×0.0×
Free cash flow yield	3.9%-4.2pp	5%-1.9pp	5.9%+0.3pp	8.2%+2.3pp	8.2%+1.2pp
Earnings yield	5%-3.8pp	6.4%-1.2pp	6.7%-0.3pp	9.5%+2.4pp	8.7%-1.0pp
PEG ratio	3.2×+2.4×	1.3×+0.7×	1×+0.4×	0.7×0.0×	0.7×+0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about United Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are United Therapeutics's profit margins?: United Therapeutics (UTHR) runs a 86.6% gross margin and a 45.3% operating margin, with a 40.6% net margin.
Where do United Therapeutics's ratios come from?: Every ratio is computed from United Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.